![Chemical structure of 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-1,2-dihydropyrimidin-2-one, CAS 143491-57-0](https://api.angenesci.com/structure/498/143491-57-0.png)
No data
No data
No data
| CAS Number | 143491-57-0 |
| Catalog Number | AG00HWXM(AGN-PC-0PU4Q0) |
| Chemical Name | 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-1,2-dihydropyrimidin-2-one |
| EC Number | 604-363-1 |
| IUPAC Name | 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one |
| InChI | InChI=1S/C8H10FN3O3S/c9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5/h1,5-6,13H,2-3H2,(H2,10,11,14)/t5-,6+/m0/s1 |
| InChI Key | XQSPYNMVSIKCOC-NTSWFWBYSA-N |
| MDL Number | MFCD00870151 |
| Molecular Formula | C8H10FN3O3S |
| Molecular Weight | 247.2467 |
| SMILES | NC1=NC(N(C=C1F)[C@@H]1CS[C@@H](O1)CO)=O |
| UNII | G70B4ETF4S |
| Synonyms | Beta L 2',3' dideoxy 5 fluoro 3' thiacytidine,
beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine,
Coviracil,
emtricitabine,
Emtriva,
Emtricitabine,
143491-57-0,
Emtriva,
Coviracil,
(-)-FTC,
Racivir,
4-amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one,
Emtritabine,
143491-54-7,
dOTFC,
524W91,
BW-524W91,
2-FTC,
BW524W91,
(-)-2'-Deoxy-5-fluoro-3'-thiacytidine,
UNII-G70B4ETF4S,
DRG-0208,
2'-Deoxy-5-fluoro-3'-thiacytidine,
BW 524W91,
BW 1592,
2',3',5-FTC,
CHEBI:31536,
3'-Thia-2'.3'-dideoxy-5-fluorocytidine,
HSDB 7337,
FTC-(-),
2'-Deoxy-5-fluoro-3'-oxa-4'-thiocytidine,
4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one,
FTC, (-)-,
G70B4ETF4S,
1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine,
(2R-cis)-4-Amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone,
4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one,
5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine,
5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine,
(-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine,
MFCD00870151,
4-Amino-5-fluoro-1-((2R,5S)-rel-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one,
4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-1,2-dihydropyrimidin-2-one,
2',3'-Dideoxy-5-fluoro-3'-thiacytidine,
NCGC00164564-01,
2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, cis-,
C8H10FN3O3S,
PSI 5004,
Coviracil(TM),
RCV,
Emtriva(TM),
2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, rel-,
2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2R-cis)-,
2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, cis-(+-)-,
SMR002533604,
Emtricitabine [USAN:INN],
(-)-.beta.-L-FTC,
Emtricitabin,
Emtricitabina,
Emtricitabinum,
2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, rel-,
PSI-5004,
AC1Q4KUB,
CHEMBL885,
AC1L1U3I,
(-)-cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one,
DSSTox_CID_20129,
DSSTox_RID_79445,
DSSTox_GSID_40129,
SCHEMBL39708,
145213-48-5,
MLS003882429,
MLS006011556,
MLS006011987,
DTXSID0040129,
CTK4C4432,
EX-A150,
4-Amino-5-fluoro-1-((2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one,
XQSPYNMVSIKCOC-NTSWFWBYSA-N,
HMS2089I05,
HMS3713L12,
KS-00001CJ2,
ZINC3629271,
Tox21_112193,
((-))-FTC,
5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)[1,3]oxathiolan-5-yl]cytosine,
ABP001074,
ANW-58684,
BDBM50107843,
CE0036,
FTC-((-)),
s1704,
(-)-(2R,5S)-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine,
AKOS015853098,
AKOS015894950,
AM84393,
AN-7243,
CCG-220615,
CS-1370,
DB00879,
MCULE-7141046266,
NE44626,
RL01788,
RTC-020120,
SB18984,
KS-00000L28,
2',3'-Dideoxy-3-thia-5-fluorocytidine,
AJ-45141,
AS-14099,
BC213715,
HY-17427,
SC-17032,
LS-135838,
LS-173184,
ST2405540,
TC-020120,
TL8000958,
CAS-143491-57-0,
E1007,
FT-0080009,
FT-0601789,
SW220172-1,
C12599,
D01199,
24229-EP2298783A1,
24229-EP2314590A1,
AB01275429-01,
491E570,
W-201247,
W-201248,
Z1739256297,
UNII-ULS8902U4O component XQSPYNMVSIKCOC-NTSWFWBYSA-N,
(2R,5S)-4-Amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one,
.beta.-L-(-)-(2R,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine,
2(1H)-Pyrimidinone,4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-,
4-Amino-5-fluoro-1-((2R,5S)-2-hydroxymethyl-[1,3]oxathiolan-5-yl)-1H-pyrimidin-2-one,
4-Amino-5-fluoro-1-[(2R,5S)-2-hydroxymethyl)-1,3-oxathiolan-5-yl]-2-(1H-pyrimidinone,
2(1H)-Pyrimidinone,4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, rel-,
5-FLUORO-(-)-L-2',3'-DIDEOXY-3'-THIACYTIDINE; (-)-BETA-2',3'-DIDEOXY-5-FLUORO-3'-THIACYTIDINE; EMTRICITABINE; EMTRIVA,
Truvada,
Mixture Name,
Emtriva (TN),
ATRIPLA,
Coviracil (TN),
Atripla (TN),
Truvada (TN),
UNII-ULS8902U4O,
D0S9SD,
Emtricitabine (JAN/USAN/INN),
ULS8902U4O,
CID60877,
C8-H10-F-N3-O3-S,
ACN-034500,
CS-O-01419,
(-)-2',3'-Dideoxy-5-fluoro-3'-thiacytidine,
FTC,
beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine,
Beta L 2',3' dideoxy 5 fluoro 3' thiacytidine,
C122114,
D000068679,
4-amino-5-fluoro-1-[ -2- -1,3-oxathiolan-5-yl]pyrimidin-2-one,
4-Amino-5-fluoro-1-[(2R,5S)-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone,
2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-,
4-Amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-(2R-cis)-2(1H)-pyrimidinone,
4-Amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone,
Beta-L-(-)-(2R,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine,
4-amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one, 95% - 1G 1g,
ETV,
|
| Complexity | 374 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 247.043g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 16 |
| Hydrogen Bond Acceptor Count | 5 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 247.244g/mol |
| Monoisotopic Mass | 247.043g/mol |
| Rotatable Bond Count | 2 |
| Topological Polar Surface Area | 113A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | -0.6 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H315-H319-H335 |
| Packing Group | |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

